Matthew Perry

Matthew Perry has extensive work experience in the field of biosciences. Matthew currently works as a Principal Scientist at Halda Therapeutics since April 2023. Prior to this, they held the same position at Reactive Biosciences from April 2022 to April 2023. Before that, they worked at Pfizer where they started as a Senior Scientist from September 2017 to April 2019, and then became a Principal Scientist from May 2019 to May 2022. Matthew also gained experience at Anacor Pharmaceuticals, where they worked as a Research Scientist III from January 2016 to September 2017, and as a Research Scientist II from July 2014 to December 2015. Matthew'searliest work experience was as a Research Associate at the University of Washington, Seattle, from January 2007 to August 2008.

Matthew Perry earned a Bachelor of Science degree in Chemistry from the University of Washington, where they attended from 2002 to 2006. Matthew then pursued further education at UC Irvine, where they obtained a Doctor of Philosophy (Ph.D.) in Organic Chemistry from 2008 to 2013.